One dose of a bivalent or nonavalent HPV vaccine was noninferior to two doses, the randomized ESCUDDO trial found. Vaccine effectiveness was at least 97% against HPV16 or 18 infection no matter whether a participant received one or two doses of the bivalent or nonavalent vaccine.

Over the last several days, the safety and efficacy of messenger RNA, or mRNA, vaccines have come under intense scrutiny. On Tuesday, the U.S. Food and Drug Administration announced plans to limit access to future COVID-19 shots -- two of which are mRNA ...

Dr. Vadim Jucaud's lab at the Terasaki Institute has introduced a new organ-on-a-chip platform that recapitulates age-dependent immune responses, offering a more accurate testing bed for evaluating cancer vaccine performance in older adults,

A new publication reports on a model for estimating the effectiveness of the influenza vaccine each flu season. Susan Yox, RN, EdD, of Medscape spoke with Joseph Bresee, MD, Chief, Epidemiology and Prevention Branch, Influenza Division, at the Centers for ...

Amid the ongoing flu season, a new health concern is emerging, with a specific mutation of Influenza A, known as the K Variant, raising questions about vaccine efficacy. We spoke with FOX Medical Team's Dr.

Federal vaccine advisors hand-selected by anti-vaccine Health Secretary Robert F. Kennedy Jr. have voted to eliminate a recommendation that all babies be vaccinated against hepatitis B on the day of birth. The decision was made with no evidence of harm from that dose and no evidence of any benefit from the delay.